Andriy Trailin Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen Charles University Biography Publications Institution JoVE Articles Andriy Trailin has not added a biography. If you are Andriy Trailin and would like to personalize this page please email our Author Liaison for assistance. Publications Prognostic Role of Macrophages and Mast Cells in the Microenvironment of Hepatocellular Carcinoma After Resection BMC Cancer. Jan, 2024 | Pubmed ID: 38287290 MiRNA and LncRNA As Potential Tissue Biomarkers in Hepatocellular Carcinoma Non-coding RNA Research. Mar, 2024 | Pubmed ID: 38075204 Morphological Changes of the Ovarian Vein in Pelvic Venous Disorders European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery. Mar, 2024 | Pubmed ID: 37952635 Theranostics Nanomedicine Applications for Colorectal Cancer and Metastasis: Recent Advances International Journal of Molecular Sciences. Apr, 2023 | Pubmed ID: 37175627 Activated Hepatic Stellate Cells in Hepatocellular Carcinoma: Their Role As a Potential Target for Future Therapies International Journal of Molecular Sciences. Dec, 2022 | Pubmed ID: 36499616 Long Non-Coding RNA and MicroRNA Interplay in Colorectal Cancer and Their Effect on the Tumor Microenvironment Cancers. Nov, 2022 | Pubmed ID: 36358867 CTNNB1 Mutations, TERT Polymorphism and CD8+ Cell Densities in Resected Hepatocellular Carcinoma Are Associated with Longer Time to Recurrence BMC Cancer. Aug, 2022 | Pubmed ID: 35962322 T- and B-Cells in the Inner Invasive Margin of Hepatocellular Carcinoma After Resection Associate with Favorable Prognosis Cancers. Jan, 2022 | Pubmed ID: 35158872 Using Virtual Microscopy for the Development of Sampling Strategies in Quantitative Histology and Design-based Stereology Anatomia, Histologia, Embryologia. Jan, 2022 | Pubmed ID: 34806204 Chronic Active Antibody-Mediated Rejection Is Associated With the Upregulation of Interstitial But Not Glomerular Transcripts Frontiers in Immunology. 2021 | Pubmed ID: 34616398 Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software Esraa Ali1, Lenka Červenková2,3, Richard Pálek2,4, Filip Ambrozkiewicz1, Sergii Pavlov1, Wenjing Ye1, Petr Hošek2, Ondrej Daum5,6, Václav Liška2,4, Kari Hemminki1,7, Andriy Trailin1 1Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 2Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 3Department of Pathology, Third Faculty of Medicine, Charles University, 4Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 5Sikl's Institute of Pathology, Faculty of Medicine and Teaching Hospital in Pilsen, Charles University, 6Bioptická Laboratoř s.r.o., 7Department of Cancer Epidemiology, German Cancer Research Center JoVE 66743 Cancer Research
Mast Cells in the Microenvironment of Hepatocellular Carcinoma Confer Favorable Prognosis: A Retrospective Study using QuPath Image Analysis Software Esraa Ali1, Lenka Červenková2,3, Richard Pálek2,4, Filip Ambrozkiewicz1, Sergii Pavlov1, Wenjing Ye1, Petr Hošek2, Ondrej Daum5,6, Václav Liška2,4, Kari Hemminki1,7, Andriy Trailin1 1Laboratory of Translational Cancer Genomics, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 2Laboratory of Cancer Treatment and Tissue Regeneration, Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 3Department of Pathology, Third Faculty of Medicine, Charles University, 4Department of Surgery and Biomedical Center, Faculty of Medicine in Pilsen, Charles University, 5Sikl's Institute of Pathology, Faculty of Medicine and Teaching Hospital in Pilsen, Charles University, 6Bioptická Laboratoř s.r.o., 7Department of Cancer Epidemiology, German Cancer Research Center JoVE 66743 Cancer Research